-
Mashup Score: 20
Innovative oral targeted therapies are warranted for patients with human epidermal growth factor receptor 2 (HER2)–mutant non–small-cell lung cancer (NSCLC). Zongertinib is an oral, irreversible, H…
Source: www.nejm.orgCategories: General Medicine NewsTweet
-
Mashup Score: 4
Join this webinar on Thursday 26 June 2025, 19:00-20:00 CEST, where Elisa Agostinetto, Nicolò Matteo Luca Battisti, Fatima Cardoso and Véronique Diéras will discuss the management of HER2-positive metastatic breast cancer. EACCME accreditation for attending the live webinar has been applied for.
Source: us02web.zoom.usCategories: General Medicine NewsTweet-
RT @mirrorsmed: Register now and join on Thursday 26 June or on demand thereafter: https://t.co/8bpceVyIo9 🔹 Interactive, free & case-base…
-
-
Mashup Score: 9MEDTALK | MEDSIR - 13 day(s) ago
Lung cancer is the second most common cancer and the leading cause of cancer-related deaths globally. Despite advancements, over 60% of patients are diagnosed at advanced or metastatic stages, leading to poor clinical outcomes. With a 5-year survival rate of only 20-30%, the urgent need to discover targetable mutations remains. Overcoming acquired resistance to existing therapies is key to improving survival outcomes.
Source: www.medsir.orgCategories: General Medicine NewsTweet-
RT @OncoAlert: A warm invitation to MEDTALK at ESMO 2025, hosted by @wearemedsir Register: https://t.co/qaOhht8GI8 October 19th, 7:00 P…
-
-
Mashup Score: 17The OncoAlert Newsletter - 20 day(s) ago
The Latest in Oncology delivered weekly to your inbox, a simple click and you are set to go!
Source: oncoalert.m-pages.comCategories: General Medicine NewsTweet-
A warm welcome to join the @OncoAlert 🚨Newsletter The Latest in Oncology, weekly, simple and delivered straight to your inbox. As always, For Colleagues...By Colleagues!! https://t.co/DjFxZIg4PM
-
-
Mashup Score: 17The OncoAlert Newsletter - 20 day(s) ago
The Latest in Oncology delivered weekly to your inbox, a simple click and you are set to go!
Source: oncoalert.m-pages.comCategories: General Medicine NewsTweet-
A warm welcome to join the @OncoAlert 🚨Newsletter The Latest in Oncology, weekly, simple and delivered straight to your inbox. As always, For Colleagues...By Colleagues!! https://t.co/DjFxZIg4PM
-
-
Mashup Score: 17The OncoAlert Newsletter - 22 day(s) ago
The Latest in Oncology delivered weekly to your inbox, a simple click and you are set to go!
Source: oncoalert.m-pages.comCategories: General Medicine NewsTweet-
A warm welcome to join the @OncoAlert 🚨Newsletter The Latest in Oncology, weekly, simple and delivered straight to your inbox. As always, For Colleagues...By Colleagues!! https://t.co/DjFxZIg4PM
-
-
Mashup Score: 17The OncoAlert Newsletter - 22 day(s) ago
The Latest in Oncology delivered weekly to your inbox, a simple click and you are set to go!
Source: oncoalert.m-pages.comCategories: General Medicine NewsTweet-
A warm welcome to join the @OncoAlert 🚨Newsletter The Latest in Oncology, weekly, simple and delivered straight to your inbox. As always, For Colleagues...By Colleagues!! https://t.co/DjFxZIg4PM
-
-
Mashup Score: 17The OncoAlert Newsletter - 23 day(s) ago
The Latest in Oncology delivered weekly to your inbox, a simple click and you are set to go!
Source: oncoalert.m-pages.comCategories: General Medicine NewsTweet-
A warm welcome to join the @OncoAlert 🚨Newsletter The Latest in Oncology, weekly, simple and delivered straight to your inbox. As always, For Colleagues...By Colleagues!! https://t.co/DjFxZIg4PM
-
-
Mashup Score: 8
Virtual webinar hosted by VJOncology featuring presentations & discussions on selected abstracts in GI cancer from ASCO 2025. Chaired by Dr Lorenza Rimassa Moderated by Richard D Kim, Efrat Dotan & Filippo Pietrantonio 04 Sept | 18:00–20:00 CEST/ 11:00–13:00 CDT/ 17:00–19:00 BST Agenda available soon
Source: us06web.zoom.usCategories: General Medicine NewsTweet-
RT @OncoAlert: Join us for the Post-ASCO 2025 GI Cancer Highlights Webinar hosted by @VJOncology! Register: https://t.co/MBebRJREpw 🗓️ Se…
-
-
Mashup Score: 5Tomosynthesis vs Digital Mammography Screening in Women with a Family History of Breast Cancer - 27 day(s) ago
This cohort study compares the performance of digital breast tomosynthesis to conventional digital mammography in screening women with a family history of breast cancer.
Source: jamanetwork.comCategories: General Medicine NewsTweet-
RT @mirrorsmed: Tomosynthesis vs Digital Mammography Screening in Women with a Family History of #BreastCancer https://t.co/6cWp19rFWB In…
-
RT @OncoAlert: Zongertinib in Previously Treated HER2-Mutant Non–Small-Cell Lung Cancer out on NEJM https://t.co/owNwlVCMxD In a multicoh…